Mevius D J, Breukink H J, van Miert A S, Kessels B G, Jobse A S, Smit J A
Department of Large Animal Medicine and Nutrition, Veterinary Faculty, University of Utrecht, The Netherlands.
J Vet Pharmacol Ther. 1991 Jun;14(2):174-84. doi: 10.1111/j.1365-2885.1991.tb00820.x.
The effect of experimental Pasteurella haemolytica infection on the intravenous and intramuscular pharmacokinetics of flumequine was studied in dairy calves. The plasma concentration-time curve of flumequine after intravenous injection of 5 mg/kg bodyweight flumequine of a 10% solution before and after experimental infection, was best described by a three-compartment open model. After intramuscular injection of the same dosage rate of a 3% flumequine suspension is was best described by the one-compartment open model with first-order absorption. The experimental infection by intratracheal administration of infectious bovine rhinotracheitis (IBR)-virus and 5 days later intrapulmonary administration of Pasteurella haemolytica produced a clear temperature rise and signs of disease expressed as Average Health Status. Subsequently, plasma Fe and Zn concentration decreased after infection. The distribution volumes Vc, Vd(area) and Vd(ss) after infection (0.07 +/- 0.04, 1.38 +/- 0.36 and 0.50 +/- 0.11 l/kg, respectively) were smaller than those before infection, but the differences were not significant (P less than or equal to 0.1). The intravenous AUC infinity was significantly increased (21.86 +/- 3.51 to 33.85 +/- 2.97 mg.h/l, P less than or equal to 0.01) and the total body clearance (ClB) significantly decreased (0.24 +/- 0.02 to 0.15 +/- 0.01, P less than or equal to 0.01) after infection. After intramuscular injection of flumequine at 5 mg/kg as a 3% suspension, only the bioavailability, F, was significantly decreased after infection (78.5 +/- 14.3 to 59.7 +/- 21.2%, P less than or equal to 0.02). However, this had no consequences for the dosage regimen used. The urine concentration ratio flumequine:7-hydroxy-flumequine:conjugated flumequine changed from 2:1:10 before infection to 6:1:15 after infection, which indicates that hydroxylation and glucuronidation as metabolic pathways for flumequine were decreased after Pasteurella sp. infection.
在奶牛犊牛中研究了实验性溶血巴氏杆菌感染对氟甲喹静脉注射和肌肉注射药代动力学的影响。在实验感染前后,静脉注射10%溶液中5mg/kg体重氟甲喹后的血浆浓度-时间曲线,最好用三室开放模型描述。肌肉注射相同剂量率的3%氟甲喹悬浮液后,最好用具有一级吸收的单室开放模型描述。通过气管内接种传染性牛鼻气管炎(IBR)病毒并在5天后肺内接种溶血巴氏杆菌进行实验性感染,导致明显的体温升高和以平均健康状况表示的疾病体征。随后,感染后血浆铁和锌浓度降低。感染后的分布容积Vc、Vd(area)和Vd(ss)(分别为0.07±0.04、1.38±0.36和0.50±0.11l/kg)小于感染前,但差异不显著(P≤0.1)。感染后静脉注射AUC infinity显著增加(从21.86±3.51增加到33.85±2.97mg·h/l,P≤0.01),全身清除率(ClB)显著降低(从0.24±0.02降低到0.15±0.01,P≤0.01)。以3%悬浮液肌肉注射5mg/kg氟甲喹后,感染后仅生物利用度F显著降低(从78.5±14.3降低到59.7±21.2%,P≤0.02)。然而,这对所用的给药方案没有影响。氟甲喹:7-羟基-氟甲喹:结合型氟甲喹的尿浓度比从感染前的2:1:10变为感染后的6:1:15,这表明溶血巴氏杆菌感染后,作为氟甲喹代谢途径的羟基化和葡萄糖醛酸化减少。